Beclin1 was mildly increased in patients with SCCHN at late clinical stages, however, we did not determine the clinical significance of Beclin1 in patients with SCCHN (Figure 7A and B; Table S2). This evidence concerns the gene BECN1 and head and neck squamous cell carcinoma.